ArticleAnnals of neurology2021

Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease.

Matthew Rosebraugh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.